Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics
Biomarkers can contribute to clinical cancer therapeutics at multiple points along the patient's diagnostic and treatment course. Diagnostic biomarkers can screen or classify patients, while prognostic biomarkers predict their survival. Biomarkers can also predict treatment efficacy or toxicity...
Saved in:
Main Authors: | Anna D. Louie (Author), Kelsey Huntington (Author), Lindsey Carlsen (Author), Lanlan Zhou (Author), Wafik S. El-Deiry (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Absence of Biomarker-Driven Treatment Options in Small Cell Lung Cancer, and Selected Preclinical Candidates for Next Generation Combination Therapies
by: Nicholas R. Liguori, et al.
Published: (2021) -
Targeting the Integrated Stress Response in Cancer Therapy
by: Xiaobing Tian, et al.
Published: (2021) -
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
by: Alexander G. Raufi, et al.
Published: (2021) -
Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors
by: Wen-I Chang, et al.
Published: (2022) -
Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action
by: Wafik S. El-Deiry, et al.
Published: (2013)